A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

A RETROSPECTIVE case series has identified ophthalmic complications in patients using the antidiabetic drugs semaglutide and ...

The rationale for the study, according to the authors, is that “Nearly 2% of the US population received a prescription for ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine ...

Traumatic optic neuropathy is visual loss caused by trauma to the optic nerve. Injuries, classified as direct or indirect, are also characterized by location. Intracanalicular optic nerve injury ...

Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy in those with type 2 diabetes.

Intravenous; LODER: Local Drug EluteR; NAION: Nonarteritic anterior ischemic optic neuropathy ... groups that are associated with significant toxic effects. A chemical engineering approach ...

Get Instant Summarized Text (Gist) Once-weekly semaglutide use in individuals with type 2 diabetes more than doubles the risk of developing nonarteritic anterior ischemic optic neuropathy (NAION ...